Zeria Pharmaceutical Co., Ltd. manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents. It also provides cosmetics, health foods, alcoholic beverages, carbonated beverages, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, measuring equipment, and analytical equipment. The company’s primary products comprise gastrointestinal ethical products, including therapeutic agents for functional dyspepsia, ulcerative colitis, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; and proton pump inhibitors, as well as therapeutic agents for hypophosphatemia, calcium channel blocker, oral NSAID, anti-leukopenia after radiotherapy, sclerosing agents for varicose veins, topical NSAID, anti-inflammatory topical blood circulation enhancer, non-steroidal anti-inflammatory ophthalmic solution, and absorbable topical hemostat products. Its products also include OTC drugs and products, such as self-prevention, remedies for gastrointestinal diseases, western herbal medicine, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses. The company was founded in 1955 and is headquartered in Tokyo, Japan.
zeria pharmaceutical co ltd
(4559:Tokyo Stock Exchange)
10 - 11, Nihonbashi Kobuna-cho
Phone: 81 3 3663 2351
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for 4559.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact ZERIA PHARMACEUTICAL CO LTD, please visit www.zeria.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.